ResMed Inc. — Income Charts
12 quarters of history · ending 2026-03-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+10.8% +$140M
$1.43B
Cost of Revenue↑+2.9% +$15M
$540M
Gross Profit↑+16.3% +$125M
$891M
R&D↑+12.3% +$10M
$94M
SG&A↑+16.5% +$40M
$286M
D&A↑+35.0% +$15M
$59M
Operating Income↑+17.3% +$74M
$500M
EBITDA↑+18.9% +$89M
$559M
Interest Expense↑+1449.4% +$11M
$12M
Interest Income
—
Other Income/Expense↑+290.0% +$23M
$15M
Pretax Income↑+20.3% +$85M
$502M
Tax Provision↑+96.7% +$51M
$104M
Net Income↑+9.2% +$34M
$399M
Gross Margin↑+2.9pts
62.2%
Operating Margin↑+1.9pts
34.9%
Net Margin↓-0.4pts
27.9%
Effective Tax Rate↑+8.0pts
20.6%
Deferred Tax Liabilities
—
ETR Federal Statutory
—
Operating Lease Cost↓-8.5% -$2M
$19M
Revenue YoY Variation↑+2.9pts
10.8%
Income YoY Variation↑+3.5pts
17.3%
Revenue QoQ Variation↓-0.1pts
0.6%
Income QoQ Variation↓-0.5pts
1.7%